DBV Technologies SA (DBVT)
9.80
+0.25
(+2.62%)
USD |
NASDAQ |
Oct 09, 16:00
9.86
+0.06
(+0.61%)
After-Hours: 20:00
DBV Technologies Cash from Operations (Quarterly) : -52.52M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -52.52M |
| March 31, 2026 | -49.28M |
| December 31, 2025 | -35.19M |
| September 30, 2025 | -32.36M |
| June 30, 2025 | -34.46M |
| March 31, 2025 | -19.67M |
| December 31, 2024 | -12.25M |
| September 30, 2024 | -22.46M |
| June 30, 2024 | -35.07M |
| March 31, 2024 | -34.69M |
| December 31, 2023 | -13.69M |
| Date | Value |
|---|---|
| September 30, 2023 | -19.57M |
| June 30, 2023 | -25.55M |
| March 31, 2023 | -20.84M |
| December 31, 2022 | -23.88M |
| September 30, 2022 | -20.05M |
| June 30, 2022 | -10.25M |
| March 31, 2022 | -1.483M |
| December 31, 2021 | -14.44M |
| September 30, 2021 | -22.95M |
| June 30, 2021 | -30.30M |
| March 31, 2021 | -36.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cellectis SA | -14.34M |
| Akari Therapeutics Plc | -3.112M |
| EDAP TMS SA | -3.687M |
| Bicycle Therapeutics Plc | -49.69M |
| Autolus Therapeutics Plc | -25.16M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.5998M |
| Cash from Financing (Quarterly) | -0.1356M |
| Free Cash Flow | -152.18M |
| Free Cash Flow Per Share (Quarterly) | -0.58 |
| Free Cash Flow to Equity (Quarterly) | -44.30M |
| Free Cash Flow to Firm (Quarterly) | -49.68M |
| Free Cash Flow Yield | -39.08% |